Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionPrivate Advisor Group, LLC
Latest Disclosed Ownership21,888 shares
Latest Disclosed Value $ 659,264
Private Advisor Group, LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On April 24, 2026 - Private Advisor Group, LLC filed a 13F-HR form disclosing ownership of 21,888 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $659,267 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 20,985 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of 4.30% during the quarter. The current value of the position is $748,351 USD.

Private Advisor Group, LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 21,888 903 4.30 659 0.76 0.0029
2026-02-17 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 20,985 8,145 63.43 655 152.51 0.0029
2025-11-13 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,840 261 2.07 259 23.33 0.0013
2025-08-11 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,579 -248 -1.93 211 6.60 0.0011
2025-05-05 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,827 -12,788 -49.92 197 -65.07 0.0012
2025-02-03 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 25,615 -489 -1.87 565 20.00 0.0032
2024-10-22 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 26,104 2,990 12.94 470 25.33 0.0029
2024-08-05 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 23,114 1,093 4.96 376 20.97 0.0025
2024-04-30 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 22,021 2,597 13.37 310 52.71 0.0022
2024-02-06 2023-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 19,424 4,654 31.51 204 39.04 0.0016
2023-11-03 2023-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 14,770 1,790 13.79 147 50.52 0.0013
2023-08-10 2023-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,980 -200 -1.52 98 -16.38 0.0008
2023-05-10 2023-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 13,180 0 0.00 117 0.0011
2023-01-18 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 13,180 -1,227 -8.52 0 -100.00 0.0000
2022-10-14 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 14,407 -10,261 -41.60 116 -37.30 0.0013
2022-07-13 2022-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 24,668 10,851 78.53 185 42.31 0.0016
2022-05-12 2022-03-31 13F/A-1 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 13,817 -1,330 -8.78 130 7.44 0.0010
2022-05-10 2022-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,147 0 121 0.0009
2022-02-10 2021-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,147 -1,195 -7.31 121 -23.90 0.0009
2021-10-14 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 16,342 -21 -0.13 159 -1.85 0.0010
2021-08-12 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 16,363 585 3.71 162 -10.99 0.0014
2021-04-22 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,778 -2,907 -15.56 182 1.11 0.0017
2021-04-01 2020-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 18,685 -324 -1.70 180 5.26 0.0019
2020-11-02 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 19,009 -2,958 -13.47 171 -36.90 0.0022
2020-08-17 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 21,967 2,278 11.57 271 53.11 0.0038
2020-05-12 2020-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 19,689 648 3.40 177 -5.35 0.0032
2020-02-10 2019-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 19,041 -14,124 -42.59 187 19.87 0.0029
2019-11-13 2019-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 33,165 8,852 36.41 156 -30.04 0.0024
2019-08-14 2019-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 24,313 -9,941 -29.02 223 -58.40 0.0040
2019-05-13 2019-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 34,254 -4,668 -11.99 536 -10.67 0.0106
2019-02-08 2018-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 38,922 5,466 16.34 600 -16.78 0.0145
2018-11-01 2018-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 33,456 25,099 300.34 721 253.43 0.0148
2018-08-09 2018-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 8,357 -13,156 -61.15 204 -44.57 0.0033
2018-05-09 2018-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 21,513 21,513 368 0.0144
2018-02-07 2017-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 0 -21,933 -100.00 0 -100.00
2017-11-13 2017-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 21,933 10,491 91.69 347 -2.80 0.0086
2017-08-10 2017-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 11,442 -6,051 -34.59 357 -36.14 0.0097
2017-05-10 2017-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADR 881624209 17,493 633 3.75 559 -3.29 0.0156
2017-02-09 2016-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 16,860 5,503 48.45 578 12.45 0.0189
2016-11-10 2016-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 11,357 336 3.05 514 -7.22 0.0210
2016-08-09 2016-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 11,021 2,052 22.88 554 16.88 0.0224
2016-05-13 2016-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 8,969 -771 -7.92 474 -25.82 0.0229
2016-02-09 2015-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 9,740 543 5.90 639 23.12 0.0306
2015-11-13 2015-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 9,197 -2,752 -23.03 519 -26.59 0.0285
2015-08-13 2015-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 11,949 501 4.38 707 -0.84 0.0336
2015-05-13 2015-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 11,448 -656 -5.42 713 3.48 0.0411
2015-02-17 2014-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 12,104 1,925 18.91 689 25.96 0.0444
2014-11-12 2014-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 10,179 1,618 18.90 547 21.83 0.0378
2014-08-08 2014-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 8,561 1,683 24.47 449 23.69 0.0386
2014-05-15 2014-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 6,878 6,878 363 0.0383
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2015-05-13 2015-03-31 13F TEVA PHARMACEUTICAL INDS ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-02-17 2014-12-31 13F TEVA PHARMACEUTICAL INDS ADR Call 1,200 2 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.